000 | 01933 a2200529 4500 | ||
---|---|---|---|
005 | 20250514015746.0 | ||
264 | 0 | _c20011207 | |
008 | 200112s 0 0 eng d | ||
022 | _a1524-4571 | ||
024 | 7 |
_a10.1161/hh2301.100801 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAhmmed, G U | |
245 | 0 | 0 |
_aNitric oxide modulates cardiac Na(+) channel via protein kinase A and protein kinase G. _h[electronic resource] |
260 |
_bCirculation research _cNov 2001 |
||
300 |
_a1005-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBucladesine _xpharmacology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aCyclic GMP-Dependent Protein Kinases _xphysiology |
650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 3 |
650 | 0 | 4 | _aElectric Conductivity |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGuanylate Cyclase _xantagonists & inhibitors |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHeart _xphysiology |
650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMyocardium _xenzymology |
650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
650 | 0 | 4 | _aPatch-Clamp Techniques |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSodium Channel Blockers |
650 | 0 | 4 |
_aSodium Channels _xphysiology |
650 | 0 | 4 | _aVentricular Function |
700 | 1 | _aXu, Y | |
700 | 1 | _aHong Dong, P | |
700 | 1 | _aZhang, Z | |
700 | 1 | _aEiserich, J | |
700 | 1 | _aChiamvimonvat, N | |
773 | 0 |
_tCirculation research _gvol. 89 _gno. 11 _gp. 1005-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/hh2301.100801 _zAvailable from publisher's website |
999 |
_c11631659 _d11631659 |